In the assessment of 12-month price targets, analysts unveil insights for Reddit, presenting an average target of $148.12, a ...

While these new drugs are curbing enthusiasm for eating, they are also having a notable effect on food purchases.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $51.6, a high ...

McDonald’s same-store sales are falling as the Ozempic impact reshapes eating habits–here’s what it means for the fast-food ...

The Charles Schwab Corporation (NYSE: SCHW) is one of the best wide moat stocks to buy now. On June 9, Redburn-Atlantic ...

Redburn Atlantic upgraded Yum! Brands (YUM) to Buy from Neutral with a price target of $177, up from $146. The firm says Yum “presents one of the most compelling setups” in its coverage. With an ...

Individual has been with Redburn Atlantic for the last 10 years; his departure comes amid several other moves at Redburn with ...

Could GLP-1 weight loss drugs like Ozempic and changing economic winds really take a bite out of the almighty Big Mac?

McDonald's just got McSmacked by a side of science as GLP-1 weight-loss drugs threaten to shrink not just waistlines but ...

“After years of outsized pricing, McDonald’s core value perception appears to be increasingly challenged,” Redburn Atlantic wrote. “Rather than prompting trade-down from full-service or fast-casual, ...

In a report released today, Danilo Gargiulo from Bernstein maintained a Hold rating on McDonald’s (MCD – Research Report). The company’s shares closed yesterday at $304.78.

McDonald's Corp. is not alone in feeling the impact of GLP-1 weight-loss drugs, but "pricing fatigue" is a bigger problem for the fast-food giant, according to Redburn Atlantic. The equities broker ...